AG-181
/ Agios Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
June 27, 2025
AG181-C-001: Single and Multiple Ascending Dose Study and Food Effect Study for AG181
(clinicaltrials.gov)
- P1 | N=112 | Recruiting | Sponsor: Agios Pharmaceuticals, Inc. | Trial completion date: Jun 2025 ➔ Oct 2025 | Trial primary completion date: Jun 2025 ➔ Oct 2025
Trial completion date • Trial primary completion date
April 16, 2024
AG181-C-001: A Safety Study of Single and Multiple Doses of AG-181 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=120 | Recruiting | Sponsor: Agios Pharmaceuticals, Inc. | Trial completion date: Sep 2025 ➔ Jun 2025 | Trial primary completion date: Sep 2025 ➔ Jun 2025
Trial completion date • Trial primary completion date
February 29, 2024
AG181-C-001: Single and Multiple Ascending Dose Study and Pilot Food Effect Study for AG-181
(clinicaltrials.gov)
- P1 | N=120 | Recruiting | Sponsor: Agios Pharmaceuticals, Inc.
New P1 trial
1 to 3
Of
3
Go to page
1